The use of liver magnetic resonance imaging is increasing thanks to its multiparametric sequences that allow a better tissue characterization, and the use of hepatobiliary contrast agents. This review aims to evaluate gadoxetic acid enhanced magnetic resonance imaging in the diagnosis and staging of cholangiocarcinoma and its different clinical and radiological classifications proposed in the literature. We also analyze the epidemiology, risk factors in correlation with clinical findings and laboratory data.
Keywords: Cholangiocarcinoma; Cirrhosis; Gadoxetic acid; Hepatobiliary contrast materials; Liver; Magnetic resonance imaging.
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.